JW Pharmaceutical Corp
KRX:001060

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001060
Watchlist
Price: 31 700 KRW 4.62%
Market Cap: ₩755.7B

JW Pharmaceutical Corp
Investor Relations

JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Young-Sub Shin
CEO, Head of Sales & Marketing and Inside Director
No Bio Available
Mr. Sung-Yeol Lee
CEO, Head of Product Development & Management and Director
No Bio Available
Jae-Kwang Jeon
Head Managing Director and Head of Public Relation
No Bio Available
Mr. Hyun-seok Han
Head of Product Plant
No Bio Available
Kim Yong Kwan
Development Head & Internal Director
No Bio Available

Contacts

Address
SEOUL
Seoul
2477, Nambusunhwan-ro, Seocho-gu
Contacts